In this Issue

Total spending on products whose patents expired between 2012 and 2015 declined by $14.2 billion last year, according to IMS Health’s Institute for Health Care informatics. And 2016 could bring about further cost reductions.

This year’s NACDS Total Store Expo Vision 2027, a pavilion that delivers insights into the future of retailing and trade-partner collaboration through a unique blend of technology and interactivity, will once again draw attention to the future possibilities in retail pharmacy.

COLUMBUS, Ohio — Adult nutrition market leader Abbott earlier this year launched its latest adult nutrition protein booster called Ensure Enlive that’s formulated to rebuild lost muscle and regain strength and energy for those boomers with chronic illness or recovering from surgery.

Sales of OTC medicines continue on a steady pace with dollar volumes up half a billion dollars over the first half of 2016, according to data culled from IRI. Drug Store News earlier this year reported $44 billion in OTC sales for calendar 2015, citing IRI figures.

The one common denominator that will bring into focus all future visions on what retail pharmacy will look like 10 years from now is secure connectivity and big data. Successfully managing health at scale will be predicated on efficient population management algorithms that enable caregivers to successfully intercept patients before a health event occurs.

Retailers are asking for fewer — but bigger and bolder — new products and fewer flankers.

So what’s hot — and why?

PARSIPPANY, N.J. — In March, GSK Consumer Healthcare launched Children’s Flonase. If sales of the children’s liquid versions of existing allergy brands are any indication — typically pediatric SKUs represent between 10% and 25% the sales of their parent brand — Children’s Flonase could reach as high as $85 million in its first year.

CVS Pharmacy